All patients (n = 64) | Infected (n = 23) | Non-infected (n = 41) | p-value | |
---|---|---|---|---|
Invasive procedures | ||||
Surgery (n, %) | 38 (59) | 17 (74) | 21 (51) | 0.076 |
Amount of surgical procedures (n, median, IQR) | 1 (0–1) | 1 (0–3) | 1 (0–1) | 0.006 |
Tracheostomy (n, %) | 10 (16) | 8 (35) | 2 (5) | 0.002 |
Intracranial device (n, %) | 20 (31) | 12 (52) | 8 (20) | 0.007 |
Duration of Intracranial device (days, median, IQR) | 0 (0–2) | 1 (0–6) | 0 (0–0) | 0.005 |
Central venous catheter (n, %) | 26 (41) | 12 (52) | 14 (34) | 0.159 |
Duration of central venous catheter (days, median, IQR) | 0 (0–5) | 2 (0–8) | 0 (0–3) | 0.103 |
Treatment during ICU/CMC stay | ||||
Antibiotics (n, %) | 48 (75) | 19 (83) | 29 (71) | 0.292 |
SDD (n, %) | 44 (69) | 18 (78) | 26 (63) | 0.219 |
Other than SDD (n, %) | 37 (58) | 16 (70) | 21 (51) | 0.154 |
Duration of antibiotics (days, median, IQR) | 5 (1–7) | 5 (2–9) | 4 (0–7) | 0.126 |
Vasopressor (n, %) | 35 (55) | 17 (74) | 18 (44) | 0.021 |
Duration of vasopressor use (days, median, IQR) | 1 (0–2) | 1 (0–5) | 0 (0–2) | 0.016 |
Beta-blocker (n, %) | 12 (19) | 7 (30) | 5 (12) | 0.073 |
Duration of beta-blocker use (days, median, IQR) | 0 (0–0) | 0 (0–2) | 0 (0–0) | 0.066 |
Mechanically ventilated (n, %) | 61 (95) | 23 (100) | 38 (93) | 0.184 |
Duration of ventilation (days, median, IQR) | 3 (2–7) | 6 (2–11) | 2 (2–5) | 0.042 |
Outcome | ||||
Onset of (first) infection (days, median, IQR) | NA | 6 (3–12) | NA | NA |
ICU stay (days, median, IQR) | 4.5 (3–9) | 8 (3–14) | 4 (2–6.5) | 0.011 |
Total length of hospital stay (days, median, IQR) | 12 (6–26) | 24 (10–44) | 9 (5–17) | 0.001 |
Discharge location (n, %) | ||||
Home | 20 (31) | 4 (17) | 16 (39) | 0.073 |
Another hospital | 17 (27) | 8 (35) | 10 (24) | 0.375 |
Nursing home | 14 (22) | 7 (30) | 7 (17) | 0.215 |
28-day mortality (n, %) | ||||
All causes | 12 (19) | 4 (17) | 8 (19) | 0.835 |
Brain injury | 10 (8) | 3 (13) | 7 (16) | 0.670 |
MOF | 2 (3) | 1 (4) | 1 (2) | 0.674 |